Skip to content
Dose Brief
Menu

Pallas Health review

By Updated

Pallas offers branded and compounded GLP-1 care; compare the full billing term and renewal quote before choosing a prepaid discount.

Brief Score63/100Grade CNo. 322 in our directory
Visit Pallas Health View the provider’s current plans and terms.
Semaglutide

$199 every 4 weeks for compounded treatment after $139 first period; annual plan advertises $139/mo average with prepayment

Tirzepatide

$299 every 4 weeks for compounded treatment after $179 first period; annual plan advertises $239/mo average with prepayment

Coverage
Nationwide — all 50 states + DC
Brand-name
Yes

Prices checked against Pallas Health's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Compounded plans renew every four weeks, with lower advertised averages for longer prepaid terms. Confirm the full charge and supply period; a plan labeled annual may cover 48 weeks.

Pallas Health in depth

Pallas lists branded and compounded GLP-1 options, with prescribing subject to clinician review. Its compounded plans include medication, clinician oversight, care-team messaging and shipping without a separate membership fee.

The public page checked October 6 lists compounded semaglutide at $139 for the first period, then $199 every four weeks. Tirzepatide starts at $179, then renews at $299 every four weeks. It also advertises annual-plan averages of $139 and $239 per month. Its billing disclosure defines terms as 4, 12, 24 or 48 weeks, so ask for the actual prepaid charge and supply period rather than treating an annual label as 52 weeks.

Four-week billing produces 13 periods over 52 weeks, rather than 12 calendar-month bills. Luvo Health, which also sells four-week plans, prints the total charge and per-week rate at each of its term lengths. At the stated recurring rates, 13 renewals would total $2,587 for semaglutide or $3,887 for tirzepatide before any introductory discount or separate charge. This is arithmetic on the published four-week plan, not a quote for your prescription. The longer prepaid plans have different terms.

Pallas says a clinician finding treatment unsuitable triggers a full refund. Its page also says plans renew until canceled. Before prepaying, obtain the exact cancellation deadline and refund treatment for unused medication periods in writing.

The current treatment catalog includes branded injection and oral options as well as compounded products. These are different medicines and formulations, not interchangeable versions of the same purchase. Compounded drugs are not FDA-approved. Ask which product and dispensing pharmacy your clinician proposes, and confirm state eligibility before comparing costs.

Sources we checked

Public program pages and terms, checked October 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Pallas Health scored on our six Brief Score factors. See the methodology.

Price Stability50/100
Supply Reliability82/100
Transparency58/100
Access Breadth66/100
Clinical Oversight78/100
Track Record44/100

What we like

  • The treatment page describes both branded and compounded GLP-1 pathways.
  • Compounded plans include clinician care, messaging and shipping without a separate membership fee.
  • The provider says clinician-declined treatment receives a full refund.

The caveats

  • First-period prices differ from renewal charges.
  • Four-week billing is shorter than a calendar month; longer-plan averages require checking the full term charge.
  • The treatment page alone does not establish all unused-term refund rights.
  • Compounded medicines are not FDA-approved; brand and compounded treatment costs should be compared separately.
  • Our August 7 review recorded Belmar among the named dispensing pharmacies. FDA issued a March 2023 letter to Belmar Pharma Solutions, Drug Depot, LLC dba APS Pharmacy and closed it out in October 2023. This historical, closed-out pharmacy letter is not a letter against Pallas.

The brief

Best for: Readers comparing branded or compounded care who will verify the billing cycle and full prepaid amount before choosing a plan. Pallas offers branded and compounded GLP-1 care; compare the full billing term and renewal quote before choosing a prepaid discount.

Ranked #322 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Pallas Health.

Closest here

The providers scoring nearest Pallas Health — read each current assessment before choosing care.

Weighing Pallas Health against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Pallas Health, and every provider that outranks it is listed on the Pallas Health alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Pallas Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Pallas Health's site. Not medical advice; see our disclosure.

← Back to all rankings